EP0756637A1 - Methods for calibrating chemical assays - Google Patents

Methods for calibrating chemical assays

Info

Publication number
EP0756637A1
EP0756637A1 EP95914453A EP95914453A EP0756637A1 EP 0756637 A1 EP0756637 A1 EP 0756637A1 EP 95914453 A EP95914453 A EP 95914453A EP 95914453 A EP95914453 A EP 95914453A EP 0756637 A1 EP0756637 A1 EP 0756637A1
Authority
EP
European Patent Office
Prior art keywords
atp
analyte
caged
assay
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95914453A
Other languages
German (de)
French (fr)
Other versions
EP0756637B1 (en
Inventor
William John Simpson
Julian Mark Pye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRF International Co
Original Assignee
BRF International Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRF International Co filed Critical BRF International Co
Publication of EP0756637A1 publication Critical patent/EP0756637A1/en
Application granted granted Critical
Publication of EP0756637B1 publication Critical patent/EP0756637B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/968High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Definitions

  • the present invention relates to methods for calibrating chemical assays and more particularly but not exclusively to a method for calibrating assays for analytes of importance in analytical microbiology such as an assay for adenosine 5*- triphosphate (ATP) .
  • ATP adenosine 5*- triphosphate
  • Microbial biomass estimation is also important in a number of other applications, including control of waste processing, monitoring of sterilization processes and monitoring of air quality. In many cases, it is advantageous to be able to estimate the degree of microbial or chemical contamination within the shortest possible period of time.
  • assay techniques are available for detection and quantification of analytes of interest, and examples include enzymic assays, enzyme linked immunosorbent assays (ELISA) , spectrophotometric assays, luminescence assays, fluorescence assays, chromatographic assays, assays based on measurement of changes in optical rotation of test sample, ion selective assays (including titrimetric assays) and colorimetric assays.
  • the particular assay method used mainly depends upon the analyte to be detected and quantified.
  • Standardization techniques are known which use radioactive isotopes for the purpose of standardizing the instrumentation rather than the assay per se .
  • An example of such radioactive standardization is embodied in the Biolink Light Standard (Leaback, DH, Easy-to-use light standards as aids to luminometry, Szalay, A.A. et al (Eds) pp 33-37 - Bioluminescence and Chemiluminescence, Status Report. Proceedings of VII International Symposium of Bioluminescence and Chemiluminescence John Wiley & Sons, Chichester 1993) .
  • Such standards are based upon gaseous - tritium - activated phosphors which emit light of a defined spectral range and exhibit predictable decay on long term storage. Such devices serve only to assist in calibration of the luminometers themselves.
  • adenosine 5'-triphosphate is an important analyte in microbiological assays. ATP is found in live cells but not in dead cells and its presence in a sample can be indicative of microbial contamination.
  • One widely used technique for assaying ATP is an ATP bioluminescence technique.
  • ATP adenosine 5'-triphosphate
  • AMP adenosine 5'-monophosphate
  • PP- inorganic phosphate; C0 2 — carbon dioxide
  • the amount of light produced by the reaction is directly proportional to the ATP concentration and can be detected using a sensitive light detector. This is the basis of the ATP-biolu inescence assay.
  • Assays for ATP using the firefly luciferase reaction can be calibrated in two ways (Jago, P.H., Stanfield, G. Simpson, W.J. & Hammond, J.R.M. 1989. In ATP Luminescence: Rapid Methods in Microbiology, Society of Applied Bacteriology Technical Series, Vol. 26, Stanley P.E. et al. (eds) pp 53- 61) .
  • the light output from reaction of the firefly luciferase reagent with the sample can be compared to that obtained from reaction of the firefly luciferase reagent with known amounts of ATP using a standard curve.
  • the inherent activity of the firefly luciferase reagent itself may vary due to inconsistencies in production or handling. Even though the reaction' rate may be unaffected, there may be substances present in the reaction mixture which absorb the light produced to a significant extent, thus introducing error. Some substances, notably Zn 2+ , in addition to reducing the catalytic activity of firefly luciferase also change the wavelength of the light produced in the reaction. This can cause a reduced amount of light to be detected from the reaction in some types of lu inometers (Denburg, J.L. & McElroy, W.D. 1978. Arch . Biochem . Biophys . 141, 668-675) .
  • step (ii) measuring a test property of the assay; (iii) exposing the sample/photosensitive derivative mix to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of analyte; (iv) re-measuring the test property; (v) repeating steps iii) and iv) inclusive from zero-n times as desired; (vi) calculating the change in the test property measurements; and (vii) using the calculated value(s) from step (vi) as a standard to determine the amount of analyte originally present in the sample.
  • step (i) exposing a pre-determined amount of photosensitive derivative of an analyte to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of analyte; (ii) measuring a test property of the assay; (iii) repeating steps (i) and (ii) inclusive from zero-n times as desired; (iv) calculating the change in the test property measurements; and (v) using the calculated values from step (iv) as a standard against which results of an assayed sample can be compared.
  • the photosensitive derivative is in solution prior to the photolysis step, although in some circumstances it may be desirable to use the photosensitive derivative in a dried state.
  • the intensity and/or duration of the flash of visible light in step (iii) may be varied so as to compensate for a diminishing amount of photosensitive derivative available for photolysis.
  • step (viii) calculating the change in the light emission measurements; and (ix) using the calculated value(s) from step (viii) as a standard to determine the amount of ATP originally present in the sample.
  • the present method a non-radioactive, photostandardization technique, provides advantages over previously available standardization methods in respect of (i) precision and accuracy of results; (ii) verification of results; and (iii) user friendliness.
  • a range of synthetic compounds of biological interest has been developed for use in physiological studies which contain a photo-sensitive chemical bond. When one of these compounds is exposed to a brief flash of intense light, a reaction product is released.
  • the photo-sensitive compound is referred to as a *caged' compound, from which a molecule or ion of interest can be liberated.
  • ATP is released from caged- ATP
  • Ca 2+ is released from caged-Ca 2+ , and so on.
  • Such photo- sensitive analyte derivatives are suitable for the present invention and their use, together with a high intensity photoflash lamp or Q-switched frequency-doubled laser provides a convenient and non-invasive means for standardizing a chemical assay.
  • the finding that commercially available photoflash lamps can effect efficient release of analyte molecules from caged precursors is hitherto unknown.
  • a predetermined amount of the 'caged' compound can be added to the sample to be assayed, or to the buffer used to dilute the sample to be assayed.
  • a particular test property of the assay is then measured. The test property measured depends upon the assay in question but it could be emitted light, heat evolution, colour changes or other properties.
  • a predetermined amount of the free compound is then released from the caged compound by exposing the mixture to a light flash of predetermined intensity and duration.
  • the test property may then be re-measured and the change in test property measurements may be calculated.
  • the calculated value may then be used as a standard to determine the amount of analyte originally present in the sample.
  • a range of standard concentrations of the compound of interest can be produced by varying the degree of photolysis in a single strength solution of a 'caged 1 compound.
  • a calibration series can be prepared, for example on a microtitre plate, without the need to pipette different volumes of standard analyte solutions.
  • the conventional assay procedure could be followed but in selected assays, standardization could be achieved by photolysis of the 'caged' analyte prior to performing the assay step.
  • this general photostandardization system can be used with a wide variety of assay systems, including enzyme linked immunosorbent assays (ELISA) , enzymic assays, spectrophotometric assays, fluorescence assays, assays based on measurement of changes in optical rotation of the test- sample, ion-selective assays (including titrimetric assays) and colorimetric assays.
  • ELISA enzyme linked immunosorbent assays
  • enzymic assays enzymic assays
  • spectrophotometric assays spectrophotometric assays
  • fluorescence assays assays based on measurement of changes in optical rotation of the test- sample
  • ion-selective assays including titrimetric assays
  • colorimetric assays colorimetric assays.
  • a multi-point calibration rather than a single-point calibration.
  • This can be achieved by generating a calibration series by separately photolysing different solutions of a single-strength 'caged' compound (ideally in a microtitre plate or its equivalent) .
  • a degree of photolysis for example by employing one, two, three or four flashes of pre-determined intensity and duration, a set of calibration standards is obtained.
  • the amount of analyte released with each sequential flash decreases.
  • the flash intensity and/or duration it is possible to compensate for the diminishing amount of •caged' material available for photolysis, thereby resulting in production of equal quantities of analyte at each stage and generation of a linear calibration series.
  • the amount of analyte released under a standard set of photolysis conditions can be determined by reference to a separately-prepared standard curve prepared using a non-derivatized form of the analyte.
  • the concentration of photosensitive analyte in the reaction can be adjusted to achieve release of a certain amount of analyte, or the intensity and/or duration of the light flash can be adjusted to achieve the same end.
  • Some materials phosphoresce when exposed to a high intensity flash of light, such as that produced by a flash gun.
  • the intensity of such phosphorescence depends on the material.
  • phosphorescence is a source of interference. Ways of minimizing or correcting for such interference include the following (note that more than one strategy can be used at any one time) .
  • a first strategy is to introduce a time delay between the period of photolysis and the period of measurement.
  • the logarithm of the intensity of the phosphorescence decreases in proportion to the increase in the logarithm of the time elapsed.
  • a gap of a few seconds is sufficient to reduce the measured light emission to a value which is acceptable for many types of assays.
  • a second strategy is to filter either the light used to irradiate the sample (or use monochromatic light such as that from a laser source) or to filter the light emitted by the cuvette material. Both strategies can be equally or differently efficacious, depending on the materials being used.
  • a third strategy is to select materials which have a low potential to phosphoresce when exposed to the lighting conditions specified in the photostandardization protocol.
  • a further strategy is to correct the result obtained after photolysis for the light emitted as a result of phosphorescence. This can be achieved using an electronic calculating device provided that (i) the inherent phosphorescence of the material is known, (ii) materials are selected to meet a standard specification and (iii) the time at which the measurements are made after exposure to light is standardized.
  • 'caged' products are contaminated to a greater or lesser extent with 'uncaged' products.
  • the presence of 'uncaged' products must be reduced to technically insignificant levels if optimal performance of the photostandardization technique is to be realized.
  • contaminant ATP molecules can be eliminated (converted to ADP and AMP which do not react with firefly luciferase) by reacting the caged-ATP with an ATP-degrading enzyme such as apyrase either in a soluble or immobilized form.
  • the luciferin-luciferase reagent containing the 'caged' ATP can be incubated for 8 - 20 hours or more at 4°C. During this time firefly luciferase catalyses hydrolysis of ATP but does not affect the level of caged ATP. ATP can also be removed using any of the techniques currently known in preparative chemistry including chromatography, selective precipitation, or extraction. Techniques of a similar nature can be used to treat 'caged' forms of other analytes prior to use for the purposes of photostandardizing assays using, in many cases, methods that are generally known. In some cases it may be desirable to further purify the 'caged' material.
  • the commercially-available material consists of a pair of diastereoisomers, since the nitrophenyl group used as the photolabile 'cage' can be added to ATP in two possible configurations. While these stereoisomers have identical photochemical properties, in some applications, advantage may be obtained by the use of only one of the stereoisomers. For example, the interaction of each stereoisomer, or more specifically its ability to form inclusion complexes, with components of the assay reagent such as ⁇ -, ⁇ -, y-cyclodextrin will differ in the case of each stereoisomer.
  • Some commerically-available firefly luciferase reagents contain cyclodextrins (see, for example, Lundin, A, Anson, J & Kau, P ATP extractants neutralised by cyclodextrins Campbell, A K et al (Eds) pp 399-402 in Bioluminescence and Chemiluminescence, Fundamentals and Applied Aspects, Proceedings of the 8th International Symposium on Bioluminescence and Chemiluminescence, John Wiley & Sons, Chichester, 1994) . Stereoisomers of caged substances can be separated from one another using well-known techniques.
  • a fixed amount of the 'caged* compound can be freeze-dried onto items of equipment used to peform an assay.
  • items of equipment used to peform an assay examples include disposable pipette tips, disposable sample cuvettes, and disposable paper discs or strips.
  • the 'caged* compound which has been freeze-dried onto the item, dissolves when a liquid such as a test sample or analysis reagent is brought into contact with it.
  • a pre-determined amount of the analyte can be released from the 'caged' molecule at any time by photolysis, either when the 'caged* compound is in a dried state or in solution. This type of standardization strategy is of particular value in cases where the 'caged' compound lacks adequate stability in aqueous solution.
  • analytes which can be standardized using one or more of the aforementioned strategies include ATP, adenosine onophosphate (AMP) , cyclic adenosine monophosphate (cAMP) , adenosine diphosphate (ADP) , guanosine triphosphate (GTP) , substrates for luminogenic reactions (such as D- luciferin) , inhibitors of luminogenic reactions (such as L- luciferin) , organic acids (such as oxalic acid) , fatty acids (such as arachadonic acid) , amino acids (such as phenylalanine) , sugars (such as glucose) , sugar phosphates (such as glucose-6-phosphate) , pesticides (such as atrazine) , naturally-occuring toxicants (such as ochratoxin A) , antibiotics (such as benzyl penicillin) , and compounds of pharmacological interest (such as dopamine, norepin
  • ATP a photosensitive derivative of ATP
  • ATP derivatives a nitrophenol ester of ATP which contains a photohydrolysable ester bond ( Figure 1) .
  • Other members of this group of compounds could be substituted for the nitrophenol.
  • a further example of a suitable ATP derivative is l-(4,5-dimethoxy-2-nitrophenyl) diazoethane (DMNPE) .
  • Caged ATP has been used in a number of research applications relating to a variety of areas, including the study of muscle biochemistry. (Goldman, Y.E., Hibbard, M.G. McCray, J.A. & Trentha , D.R. 1982, Nature, 300, 701-705). It has not been previously suggested or used for the purpose of calibrating biochemical or microbiological assays.
  • the yield of ATP from caged-ATP has been shown to be independent of pH over the pH range 6-9; furthermore, caged- ATP has been shown to be convenient to work with in that it is soluble in water at neutral pH and is not significantly photolyzed during several minutes exposure to subdued daylight (McCray, J.A. Herbette, L. Kihara, T. & Trentham, D.R. 1980, Proc. Natl. Acad. Sci., USA, 77, 7237-7241).
  • a caged- ATP compound is incorporated into a firefly luciferase reagent at a pre-determined concentration.
  • Firefly luciferase does not display any catalytic activity toward caged-ATP (see Example 1) , and therefore in the absence of added ATP, no light is produced from such a luciferase preparation.
  • the reagent may be used to perform highly sensitive assays of ATP in the following way:-
  • a sample and the reagent are mixed in a disposable luminometer cuvette.
  • the sample may consist of an aqueous fluid of any origin or may be a specially prepared "extract" produced as a result of treatment with any of a variety of agents designed to release ATP from living organisms.
  • the light emitted from the luminescent reaction is measured using a luminometer.
  • a known amount of ATP is then released into the reaction mixture by exposing the cuvette together with its contents to a flash of visible light of high intensity, delivered from e.g. a photoflash lamp.
  • the cuvette is then placed back into the luminometer and the light emission from the luciferase reaction measured once again. Since the light flash causes the release of a known amount of ATP from the caged-ATP present, the amount of light attributable to the presence of this known amount of ATP can be calculated by difference.
  • the amount of ATP originally present in the reaction mixture can then be calculated.
  • Caged-ATP (Calbiochem, USA, prod. no. 119127,5 mg) was dissolved in 0.5 ml sterile de-ionized water. The resulting stock solution was stored frozen at -20°C until required. Before use, it was diluted 1 in 1000 with sterile de-ionized water. To 3 ml of a commercially-available luciferase- luciferin reagent (Biotrace XT reagent, Biotrace Ltd., Bridgend, UK) was added 200 ⁇ l of sterile de-ionized water to form a control reagent or 200 ⁇ l of the caged-ATP stock solution to form a caged-ATP reagent. The reagents were then incubated for 1-6 hours at 20°C.
  • sterile de-ionized water 300 ⁇ l was transferred to a clean disposable luminometer cuvette then 100 ⁇ l of control reagent or caged-ATP reagent added.
  • the light emitted from the reaction was quantified using a Biotrace M3 Luminometer (Biotrace Ltd, Bridgend, UK) , which integrated the light response for 10 seconds after a 2 second delay.
  • a volume of ATP solution (10 ⁇ l, 0.1 ⁇ M) was then added to the reaction mixture and the light output measured for a second time.
  • caged-ATP might release ATP either by spontaneous hydrolysis, as a result of enzymic action, and/or by photolysis.
  • the results shown in Example 1 indicate that release of ATP by the former two mechanisms is negligible and that, on exposure to a high intensity flash of light produced by a flashgun, ATP is produced rapidly from the caged-ATP present. Notes to Table l
  • the high intensity photoflash (provided by a Hanimex 325A2 flash gun, Hanimex, UK) did not induce luminescence from empty cuvettes, nor from cuvettes containing test solutions such as water or caged-ATP, or luciferase-luciferin reagents in the absence of caged- ATP.
  • the "ATP photostandard” (caged-ATP) produced 1.171 pmol ATP/assay on exposure to a high intensity photoflash.
  • a luciferase/luciferin reagent which contained caged-ATP was prepared by adding caged-ATP to Biotrace MLX reagent (Biotrace, UK) to a concentration such that each 100 ⁇ l of reagent contained 43.1 pmol of caged-ATP (ie 431 nmol/1) . This reagent was incubated overnight at 4°C to reduce the background light emission.
  • the assays were carried out as follows.
  • ATP was added to a series of tubes (1 pmol per tube in 10 ⁇ l sterile de-ionized water) then 290 ⁇ l of trichloroacteic acid (TCA) solution in HEPES/EDTA buffer (original pH value of the buffer was 7.75) added.
  • TCA trichloroacteic acid
  • Luminescence was initiated in the case of each sample by adding 100 ⁇ l of the modified luciferase/luciferin reagent. The resulting light output was recorded in a Biotrace Multilite luminometer. The cuvette was then removed from the luminometer and exposed to a high intensity flash of light using a photoflash lamp which was mounted in a device of our own design (Serial number 005) . The cuvette was then placed back in the luminometer and the light produced by the reaction recorded for a second time.
  • the ATP content of each tube was calculated on the assumption that each photolysis step resulted in formation of 1.15 pmol of ATP. All tests were carried out in duplicate.
  • Caged-ATP (Calbiochem, USA) was dissolved in sterile de- ionized water to a final concentration of 14.4 ⁇ mol/1. Portions (300 ⁇ l) of the solution were transferred to clean disposable cuvettes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis, the solutions were analysed by adding 100 ⁇ l of luciferase/luciferin reagent (Biotrace MLX reagent, Biotrace pic, UK) . The light emitted was quantified using a Biotrace Multilite luminometer which integrated the light signal for 10 seconds after a two-second delay.
  • luciferase/luciferin reagent Biotrace MLX reagent, Biotrace pic, UK
  • Phosphorescence of cuvettes can lead to significant light emission occurring from samples exposed to the lighting conditions used to photostandardize assays.
  • the rate of decay of phosphorescence from such cuvettes is linear when plotted as a logarithmic plot.
  • Caged-ATP solution (14.3 mmol/1; 10 ⁇ l) was added to 1 ml Lu it buffer (HEPES/EDTA/Mg buffer, pH 7.75; Lumac bv) containing 5 ⁇ l/ l of apyrase solution.
  • the potato apyrase was a commercial preparation (So ase) obtained from Lumac bv and was reconstituted by adding 1 ml Lumit buffer to a vial of apyrase. At various times, 20 ⁇ l of this solution was transferred to clean disposable luminometer cuvettes containing 300 ⁇ l sterile de-ionized water. The light emitted by the sample was measured using a Biotrace Multilite luminometer (Biotrace, UK) .
  • the cuvette was then removed from the luminometer and placed in a flash device of our own design. After receiving a single flash from a photoflash tube, the cuvette was returned to the luminometer and the light emission measured once again. Control experiments monitored the light output from reactions in which Lumit buffer was added to the sample of caged-ATP, rather than apyrase solution.
  • the luminometer can not measure light outputs in excess of 1000000 RLU. Counts approaching this limit may behave in a non-linear way.
  • a solution of caged-ATP (14.3 mmol/1; 10 ⁇ l) was transferred to 1 ml HEPES/EDTA/Mg buffer, pH 7.75 (Lumit buffer, Lumac bv) and 5 ⁇ l of a solution of potato apyrase added.
  • the potato apyrase was a commercial preparation (Somase) obtained from Lumac bv and was reconstituted by adding 1 ml Lumit buffer to a vial of apyrase.
  • the solution of caged-ATP containing the apyrase was incubated at 20°C for 40 min then diluted 1:1 with Lumit buffer.
  • Portions (1 ⁇ l) of the solution were transferred to clean disposable plastic cuvettes (obtained from Biotrace pic) . This procedure resulted in each cuvette containing 143 pmol of caged-ATP.
  • the cuvettes were then placed in a vacuum desiccator and freeze-dried at - 55°C under vacuum for two hours.
  • the cuvettes were tested as follows. Sterile, de-ionized water (300 ⁇ l) was transferred to each cuvette then 100 ⁇ l luciferase/luciferin reagent (Biotrace MLX 24 reagent, Biotrace pic) added. The light emitted was recorded using a Biotrace Multilite luminometer, then ATP was released from the caged-ATP present using a photoflash lamp contained in a device constructed at BRF International (Box serial number 002) . The following results were obtained on replicate cuvettes,
  • ATP could also be released from the freeze-dried material contained in the cuvettes by flashing, prior to addition of any samples or reagents to the cuvette. In performing such tests, the following results were obtained.
  • Example 7 Preparation of a series of standard solutions of known concentration using caged-arachidonic acid' and varying quanta of light
  • Caged-arachidonic acid (Molecular Probes Inc, USA; product number A-7062) is dissolved in HEPES/EDTA buffer (pH 7.75) to a final concentration of 14.4 ⁇ mol/1. Portions (100 ⁇ l) of the solution are transferred to clean disposable tubes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis, the solutions are analysed using any method suitable for quantification of arachidonic acid, such as HPLC, GC/MS, TLC or specific enzymic methods.
  • HEPES/EDTA buffer pH 7.75
  • Portions (100 ⁇ l) of the solution are transferred to clean disposable tubes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis, the solutions are analysed using any method suitable for quantification of arachidonic acid, such as HPLC, GC/MS, TLC or specific enzymic methods.
  • a 'calibration curve' can be produced in this way which is analagous to that which could have been prepared by pipetting equal volumes of standard solutions, of different concentrations, into separate vials.
  • the photostandardization technique as described allowed the same result to be achieved with substantial savings in operator effort.
  • the technique is also non-invasive in nature.
  • Caged-penicillin V (Molecular Probes Inc, USA: product number P-7061) is dissolved in HEPES/EDTA buffer (pH 7.75) to a final concentration of 14.4 ⁇ mol/1. Portions (100 ⁇ l) of the solution are transferred to clean disposable tubes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis the solutions are analysed using any method suitable for quantification of penicillin V, for example using an ELISA test.
  • a , 'calibration curve' can be produced in this way which is analagous to that which could have been prepared by pipetting equal volumes of standard solutions, of different 26 concentrations, into separate vials.
  • the photostandardization technique as described allowed the same result to be achieved with substantial savings in operator effort. • ⁇ The technique is also non-invasive in nature.
  • caged analytes which could be used in methods analagous to examples 7 and 8 include caged aspartic acid (Molecular Probes Inc USA: product number A-2505) , caged L-lysine (Molecular Probes Inc USA: product number B-7099) , caged L-epinephrine (Molecular Probes Inc USA: product number D-7057) , caged L-dopamine (Molecular Probes Inc USA: product number D-7064) , caged L-phenylalanine (Molecular Probes Inc USA: product number D-7093) and caged D-luciferin (Molecular Probes Inc USA: product number L-7085) .

Abstract

PCT No. PCT/GB95/00794 Sec. 371 Date Apr. 7, 1997 Sec. 102(e) Date Apr. 7, 1997 PCT Filed Apr. 6, 1995 PCT Pub. No. WO95/27797 PCT Pub. Date Oct. 19, 1995Methods for internally and externally photostandardizing chemical assays, e.g. an ATP-bioluminescence assay. A pre-determined amount of a photosensitive derivative of the analyte of interest is used in the assay protocol which releases a known amount of the free analyte when it is exposed to a flash of visible light of pre-determined duration and intensity. By monitoring the response of a test property of the assay to the release of a known quantity of analyte, a standard value can be calculated which allows either direct determination of the amount of analyte originally present in the assayed sample or production of a photocalibration series against which results of an assayed sample can be compared.

Description

Methods For Calibrating Chemical Assays
The present invention relates to methods for calibrating chemical assays and more particularly but not exclusively to a method for calibrating assays for analytes of importance in analytical microbiology such as an assay for adenosine 5*- triphosphate (ATP) .
Accurate detection and quantification of particular substances or microorganisms for analytical purposes are essential laboratory tools. Detection and quantification of contaminant substances or contaminant microorganisms for the purposes of product or process control, or for food safety reasons, are of paramount importance to the food and beverage industries. Microbial biomass estimation is also important in a number of other applications, including control of waste processing, monitoring of sterilization processes and monitoring of air quality. In many cases, it is advantageous to be able to estimate the degree of microbial or chemical contamination within the shortest possible period of time.
Numerous assay techniques are available for detection and quantification of analytes of interest, and examples include enzymic assays, enzyme linked immunosorbent assays (ELISA) , spectrophotometric assays, luminescence assays, fluorescence assays, chromatographic assays, assays based on measurement of changes in optical rotation of test sample, ion selective assays (including titrimetric assays) and colorimetric assays. The particular assay method used mainly depends upon the analyte to be detected and quantified.
It is essential that the particular assay method chosen be as accurate and as reproducible as possible. In order to maximize the accuracy of such assays, standardization or calibration of the assay is important. A variety of factors can affect the assay reaction and may give rise to sources of error and thus the effects of these factors must be minimized or taken into account.
Standardization techniques are known which use radioactive isotopes for the purpose of standardizing the instrumentation rather than the assay per se . An example of such radioactive standardization is embodied in the Biolink Light Standard (Leaback, DH, Easy-to-use light standards as aids to luminometry, Szalay, A.A. et al (Eds) pp 33-37 - Bioluminescence and Chemiluminescence, Status Report. Proceedings of VII International Symposium of Bioluminescence and Chemiluminescence John Wiley & Sons, Chichester 1993) . Such standards are based upon gaseous - tritium - activated phosphors which emit light of a defined spectral range and exhibit predictable decay on long term storage. Such devices serve only to assist in calibration of the luminometers themselves.
It is equally important that the assay per se is also calibrated or standardized so that variations in sample and reagent compositions can be taken into account.
For example, adenosine 5'-triphosphate (ATP) is an important analyte in microbiological assays. ATP is found in live cells but not in dead cells and its presence in a sample can be indicative of microbial contamination.
One widely used technique for assaying ATP is an ATP bioluminescence technique.
In the presence of a purified enzyme (luciferase) from the American firefly, Photinuε pyralis , a substrate, D- luciferin, and sufficient magnesium ions and dissolved oxygen, the following reaction takes place: Mg-ATP + 02 + D-luciferin
I firefly luciferase oxyluciferin + AMP + PP; + C02 + light
(ATP = adenosine 5'-triphosphate; Mg-magnesium ions; 02 = oxygen; AMP = adenosine 5'-monophosphate; PP- = inorganic phosphate; C02 — carbon dioxide)Λ.
Under appropriate conditions, the amount of light produced by the reaction is directly proportional to the ATP concentration and can be detected using a sensitive light detector. This is the basis of the ATP-biolu inescence assay.
Assays for ATP using the firefly luciferase reaction can be calibrated in two ways (Jago, P.H., Stanfield, G. Simpson, W.J. & Hammond, J.R.M. 1989. In ATP Luminescence: Rapid Methods in Microbiology, Society of Applied Bacteriology Technical Series, Vol. 26, Stanley P.E. et al. (eds) pp 53- 61) .
According to an external standardization technique, the light output from reaction of the firefly luciferase reagent with the sample can be compared to that obtained from reaction of the firefly luciferase reagent with known amounts of ATP using a standard curve.
While this technique is convenient and requires a minimum of reagent manipulation, it is also subject to error. This is because the light output from firefly luciferase reactions is directly related to the rate of reaction. While the ATP concentration does indeed make a major contribution to controlling the reaction rate, it is not the sole determinant. Inhibitors present in the sample (eg. metal ions, hydrogen ions) can reduce reaction rate, and stimulators such as detergents can increase reaction rate (Simpson, W.J. and Hammond, J.R.M. 1991. Journ . Chemil min . & Biolumin . , 6, 97- 106) . In addition, the inherent activity of the firefly luciferase reagent itself may vary due to inconsistencies in production or handling. Even though the reaction' rate may be unaffected, there may be substances present in the reaction mixture which absorb the light produced to a significant extent, thus introducing error. Some substances, notably Zn2+, in addition to reducing the catalytic activity of firefly luciferase also change the wavelength of the light produced in the reaction. This can cause a reduced amount of light to be detected from the reaction in some types of lu inometers (Denburg, J.L. & McElroy, W.D. 1978. Arch . Biochem . Biophys . 141, 668-675) .
All of these sources of error can be eliminated if the standard curve approach is abandoned in favour of the internal standardization technique. In its simplest form, this consists of adding a known amount of ATP, contained in a small volume of liquid, to an initiated firefly luciferase reaction. The light output from sample and luciferase alone, and from sample and luciferase and ATP are compared, and the ATP content of the sample then calculated. This method frees the operator of analysis errors associated with variable sample composition.
The cornerstone of this technique however, is the use of a stable ATP standard solution. A great deal of controversy exists with regard to the stability of such ATP standard solutions. Some workers claim that such dilute solutions of ATP are unstable and must be kept away from light and/or stored on ice. Also problems can be experienced due to poor handling of the solution. By far the largest threat to the stability of ATP standard solutions is the presence of contaminant microorganisms in the solution. ATP is rapidly utilized by many microorganisms (Karl, D.M. 1980. Microbiol .
Rev. 44, 739-796) , and therefore their exclusion from ATP standard solutions is essential. Aseptic technique is mandatory. Although pre-weighed vials of ATP can be purchased from some specialist luminescent reagent manufacturers, their use is not widespread on account of these perceived limitations. These problems become all the moire important when ATP-bioluminescence assays are employed in safety- critical areas such as monitoring of food hygiene and air quality.
Although illustrated by the ATP-bioluminescence technique, the problems of standardizing an assay equally apply to other assay methods.
It is an object of the present invention to ameliorate the problems of standardizing chemical assays by the use of an internal photostandardization technique.
According to the present invention there is provided a method for internally standardizing a chemical assay comprising the steps:
(i) adding a pre-determined amount of photosensitive derivative of an analyte to a sample to be assayed,
(ii) measuring a test property of the assay; (iii) exposing the sample/photosensitive derivative mix to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of analyte; (iv) re-measuring the test property; (v) repeating steps iii) and iv) inclusive from zero-n times as desired; (vi) calculating the change in the test property measurements; and (vii) using the calculated value(s) from step (vi) as a standard to determine the amount of analyte originally present in the sample.
It is another object of the present invention to ameliorate the problems of standardizing chemical assays by production of a photocalibration series.
According to another aspect of the present invention there is provided a method for externally standardizing a chemical assay comprising the steps:
(i) exposing a pre-determined amount of photosensitive derivative of an analyte to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of analyte; (ii) measuring a test property of the assay; (iii) repeating steps (i) and (ii) inclusive from zero-n times as desired; (iv) calculating the change in the test property measurements; and (v) using the calculated values from step (iv) as a standard against which results of an assayed sample can be compared.
Preferably the photosensitive derivative is in solution prior to the photolysis step, although in some circumstances it may be desirable to use the photosensitive derivative in a dried state.
In circumstances where a multi-point calibration procedure is desired the intensity and/or duration of the flash of visible light in step (iii) may be varied so as to compensate for a diminishing amount of photosensitive derivative available for photolysis.
It is a further object of the present invention to provide a method of standardizing an ATP-bioluminescence assay.
According to a further aspect of the present invention there is provided a method for standardizing an ATP- bioluminescence assay comprising the steps:
(i) incorporating a pre-determined amount of a photosensitive derivative of ATP into a firefly luciferase - luciferin reagent,
(ii) measuring the light emitted by the reagent;
(iii) mixing a sample to be assayed with the reagent;
(iv) re-measuring the light emitted by the luminescent reaction; (v) exposing the sample/reagent mixture to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of ATP;
(vi) re-measuring the light emitted by the luminescent reaction;
(vii) repeating steps v) and vi) inclusive from zero-n times as desired;
(viii) calculating the change in the light emission measurements; and (ix) using the calculated value(s) from step (viii) as a standard to determine the amount of ATP originally present in the sample.
The present method, a non-radioactive, photostandardization technique, provides advantages over previously available standardization methods in respect of (i) precision and accuracy of results; (ii) verification of results; and (iii) user friendliness.
Enhanced precision results from the elimination of pipetting errors associated with analyte standard addition, and from compensation for any changes in optical or catalytic quenching associated with assay dilution. The ability to apply a simple, valid standardization protocol is likely to give benefits in the form of facilitated result verification, a point of particular significance with respect to Food and Standards legislation and certain safety-critical applications. Improved user friendliness results from the facts that no separate analyte standard solution 'is necessary to perform such assays, and that the assay reagents can be factory calibrated. Furthermore, standardization of the assay may be completely independent of the method used to detect or quantify the analyte of interest.
A range of synthetic compounds of biological interest has been developed for use in physiological studies which contain a photo-sensitive chemical bond. When one of these compounds is exposed to a brief flash of intense light, a reaction product is released. The photo-sensitive compound is referred to as a *caged' compound, from which a molecule or ion of interest can be liberated. Hence, ATP is released from caged- ATP, Ca2+ is released from caged-Ca2+, and so on. Such photo- sensitive analyte derivatives are suitable for the present invention and their use, together with a high intensity photoflash lamp or Q-switched frequency-doubled laser provides a convenient and non-invasive means for standardizing a chemical assay. The finding that commercially available photoflash lamps can effect efficient release of analyte molecules from caged precursors is hitherto unknown.
According to a first preferred method of the present invention a predetermined amount of the 'caged' compound can be added to the sample to be assayed, or to the buffer used to dilute the sample to be assayed. A particular test property of the assay is then measured. The test property measured depends upon the assay in question but it could be emitted light, heat evolution, colour changes or other properties.
A predetermined amount of the free compound is then released from the caged compound by exposing the mixture to a light flash of predetermined intensity and duration. The test property may then be re-measured and the change in test property measurements may be calculated. The calculated value may then be used as a standard to determine the amount of analyte originally present in the sample.
Alternatively, in another preferred method of the present invention, a range of standard concentrations of the compound of interest can be produced by varying the degree of photolysis in a single strength solution of a 'caged1 compound. In this way, a calibration series can be prepared, for example on a microtitre plate, without the need to pipette different volumes of standard analyte solutions. In this format, for test assays, the conventional assay procedure could be followed but in selected assays, standardization could be achieved by photolysis of the 'caged' analyte prior to performing the assay step.
Accordingly, this general photostandardization system can be used with a wide variety of assay systems, including enzyme linked immunosorbent assays (ELISA) , enzymic assays, spectrophotometric assays, fluorescence assays, assays based on measurement of changes in optical rotation of the test- sample, ion-selective assays (including titrimetric assays) and colorimetric assays.
In cases where maximum possible precision and accuracy are required of test procedures, it may be desirable to peform a multi-point calibration, rather than a single-point calibration. This can be achieved by generating a calibration series by separately photolysing different solutions of a single-strength 'caged' compound (ideally in a microtitre plate or its equivalent) . By varying the degree of photolysis, for example by employing one, two, three or four flashes of pre-determined intensity and duration, a set of calibration standards is obtained.
However, this approach is not suitable where the measurement and calibration must take place in the same tube, in a non-invasive manner and where the analyte must be present at a specific step of the assay protocol such as the beginning of the protocol. It is possible, however, to perform a multi¬ point calibration in some single tube assays such as an ATP- bioluminescence assay. This results from the fact that such assay protocols are robust to the point at which the analyte is released into the test solution. Under some circumstances, multi-point calibration of single tube assays may be superior in terms of accuracy and precision to single point calibration of such tests.
In devising such procedures it is important to optimise the relationship between the total amount of 'caged' material available for photolysis and the intensity of the light source. In the case of assays which are standardized by means of a single-point calibration procedure, it is desirable to use as little 'caged' material as possible in the reaction and to maximise the conversion of 'caged' material to analyte by using light of sufficient intensity to release >50% of the analyte from the 'caged' material. However, in the case of assays which are to be standardized by means of a multi-point calibration procedure, it is essential to limit the conversion of 'caged' analyte to free analyte by using light of an intensity which is only capable of effecting the release of 1 - 2% of the analyte on exposure to the first period of photolysis. Consequently, to ensure that a sufficient amount of analyte is released, the total concentration of a 'caged' material present in the assay must be higher than is the case in reagents designed for use with single-point calibrations.
When using light flashes of fixed intensity and duration, the amount of analyte released with each sequential flash decreases. By varying the flash intensity and/or duration, it is possible to compensate for the diminishing amount of •caged' material available for photolysis, thereby resulting in production of equal quantities of analyte at each stage and generation of a linear calibration series. In practice, the amount of analyte released under a standard set of photolysis conditions can be determined by reference to a separately-prepared standard curve prepared using a non-derivatized form of the analyte. The concentration of photosensitive analyte in the reaction can be adjusted to achieve release of a certain amount of analyte, or the intensity and/or duration of the light flash can be adjusted to achieve the same end.
Some materials phosphoresce when exposed to a high intensity flash of light, such as that produced by a flash gun. The intensity of such phosphorescence depends on the material. In tests in which estimates of analyte concentration are made by measurement of emitted light (eg. tests based on bioluminescence, chemiluminescence and fluorescence) , phosphorescence is a source of interference. Ways of minimizing or correcting for such interference include the following (note that more than one strategy can be used at any one time) .
A first strategy is to introduce a time delay between the period of photolysis and the period of measurement. The logarithm of the intensity of the phosphorescence decreases in proportion to the increase in the logarithm of the time elapsed. As a result, a gap of a few seconds is sufficient to reduce the measured light emission to a value which is acceptable for many types of assays.
A second strategy is to filter either the light used to irradiate the sample (or use monochromatic light such as that from a laser source) or to filter the light emitted by the cuvette material. Both strategies can be equally or differently efficacious, depending on the materials being used.
A third strategy is to select materials which have a low potential to phosphoresce when exposed to the lighting conditions specified in the photostandardization protocol.
Materials in common laboratory use diffe substantially in their phosphoresence characteristics when exposed to a standard polychromatic light source in the form of a photoflash lamp.
A further strategy is to correct the result obtained after photolysis for the light emitted as a result of phosphorescence. This can be achieved using an electronic calculating device provided that (i) the inherent phosphorescence of the material is known, (ii) materials are selected to meet a standard specification and (iii) the time at which the measurements are made after exposure to light is standardized.
Most 'caged' products, whether obtained commercially, or produced in the laboratory using common-place techniques, are contaminated to a greater or lesser extent with 'uncaged' products. The presence of 'uncaged' products must be reduced to technically insignificant levels if optimal performance of the photostandardization technique is to be realized. In the case of caged-ATP, contaminant ATP molecules can be eliminated (converted to ADP and AMP which do not react with firefly luciferase) by reacting the caged-ATP with an ATP-degrading enzyme such as apyrase either in a soluble or immobilized form. Alternatively, the luciferin-luciferase reagent containing the 'caged' ATP can be incubated for 8 - 20 hours or more at 4°C. During this time firefly luciferase catalyses hydrolysis of ATP but does not affect the level of caged ATP. ATP can also be removed using any of the techniques currently known in preparative chemistry including chromatography, selective precipitation, or extraction. Techniques of a similar nature can be used to treat 'caged' forms of other analytes prior to use for the purposes of photostandardizing assays using, in many cases, methods that are generally known. In some cases it may be desirable to further purify the 'caged' material. For example, in the case of a l-(2- nitrophenyl) ethyl ester of ATP, the commercially-available material consists of a pair of diastereoisomers, since the nitrophenyl group used as the photolabile 'cage' can be added to ATP in two possible configurations. While these stereoisomers have identical photochemical properties, in some applications, advantage may be obtained by the use of only one of the stereoisomers. For example, the interaction of each stereoisomer, or more specifically its ability to form inclusion complexes, with components of the assay reagent such as α-, β-, y-cyclodextrin will differ in the case of each stereoisomer. Some commerically-available firefly luciferase reagents contain cyclodextrins (see, for example, Lundin, A, Anson, J & Kau, P ATP extractants neutralised by cyclodextrins Campbell, A K et al (Eds) pp 399-402 in Bioluminescence and Chemiluminescence, Fundamentals and Applied Aspects, Proceedings of the 8th International Symposium on Bioluminescence and Chemiluminescence, John Wiley & Sons, Chichester, 1994) . Stereoisomers of caged substances can be separated from one another using well-known techniques.
It is envisaged that in some circumstances a fixed amount of the 'caged* compound can be freeze-dried onto items of equipment used to peform an assay. Examples of such items include disposable pipette tips, disposable sample cuvettes, and disposable paper discs or strips. In use, the 'caged* compound, which has been freeze-dried onto the item, dissolves when a liquid such as a test sample or analysis reagent is brought into contact with it. A pre-determined amount of the analyte can be released from the 'caged' molecule at any time by photolysis, either when the 'caged* compound is in a dried state or in solution. This type of standardization strategy is of particular value in cases where the 'caged' compound lacks adequate stability in aqueous solution. In the dried state, the stability of most 'caged' compounds to hydrolysis and oxidation is markedly increased. In enzyme assays, such as those in which an analyte is converted to a different compound by enzymic action, conversion of the analyte may be coupled to reduction of a flavin nucleotide such as nicotinamide adenine dinucleotide, or to production of a compound such as ATP. A 'caged' form of the 'secondary' analyte (eg NADH or ATP) can be incorporated into the reaction mixture and released, when i desired, by photolysis. As a result, standardization of such assays is achieved without the need to prepare separate solutions of standard material, saving both time and operator effort.
Examples of analytes which can be standardized using one or more of the aforementioned strategies include ATP, adenosine onophosphate (AMP) , cyclic adenosine monophosphate (cAMP) , adenosine diphosphate (ADP) , guanosine triphosphate (GTP) , substrates for luminogenic reactions (such as D- luciferin) , inhibitors of luminogenic reactions (such as L- luciferin) , organic acids (such as oxalic acid) , fatty acids (such as arachadonic acid) , amino acids (such as phenylalanine) , sugars (such as glucose) , sugar phosphates (such as glucose-6-phosphate) , pesticides (such as atrazine) , naturally-occuring toxicants (such as ochratoxin A) , antibiotics (such as benzyl penicillin) , and compounds of pharmacological interest (such as dopamine, norepinephrine, serotonin, testosterone and interferon) . This list is not intended to be exhaustive, but is for the purpose of illustration.
Various photosensitive derivatives of ATP have been synthesized which release ATP. One example of these ATP derivatives is a nitrophenol ester of ATP which contains a photohydrolysable ester bond (Figure 1) . Other members of this group of compounds could be substituted for the nitrophenol. A further example of a suitable ATP derivative is l-(4,5-dimethoxy-2-nitrophenyl) diazoethane (DMNPE) . Caged ATP has been used in a number of research applications relating to a variety of areas, including the study of muscle biochemistry. (Goldman, Y.E., Hibbard, M.G. McCray, J.A. & Trentha , D.R. 1982, Nature, 300, 701-705). It has not been previously suggested or used for the purpose of calibrating biochemical or microbiological assays.
The yield of ATP from caged-ATP has been shown to be independent of pH over the pH range 6-9; furthermore, caged- ATP has been shown to be convenient to work with in that it is soluble in water at neutral pH and is not significantly photolyzed during several minutes exposure to subdued daylight (McCray, J.A. Herbette, L. Kihara, T. & Trentham, D.R. 1980, Proc. Natl. Acad. Sci., USA, 77, 7237-7241).
In order to calibrate an ATP bioluminescence reaction in accordance with the method of the present invention a caged- ATP compound is incorporated into a firefly luciferase reagent at a pre-determined concentration. Firefly luciferase does not display any catalytic activity toward caged-ATP (see Example 1) , and therefore in the absence of added ATP, no light is produced from such a luciferase preparation. The reagent may be used to perform highly sensitive assays of ATP in the following way:-
A sample and the reagent are mixed in a disposable luminometer cuvette. The sample may consist of an aqueous fluid of any origin or may be a specially prepared "extract" produced as a result of treatment with any of a variety of agents designed to release ATP from living organisms. The light emitted from the luminescent reaction is measured using a luminometer. A known amount of ATP is then released into the reaction mixture by exposing the cuvette together with its contents to a flash of visible light of high intensity, delivered from e.g. a photoflash lamp. The cuvette is then placed back into the luminometer and the light emission from the luciferase reaction measured once again. Since the light flash causes the release of a known amount of ATP from the caged-ATP present, the amount of light attributable to the presence of this known amount of ATP can be calculated by difference. The amount of ATP originally present in the reaction mixture can then be calculated.
The following non-limiting Examples are intended to describe the nature of the invention more clearly:-
Example 1 use of caged-ATP for standardization of ATP assays
Caged-ATP (Calbiochem, USA, prod. no. 119127,5 mg) was dissolved in 0.5 ml sterile de-ionized water. The resulting stock solution was stored frozen at -20°C until required. Before use, it was diluted 1 in 1000 with sterile de-ionized water. To 3 ml of a commercially-available luciferase- luciferin reagent (Biotrace XT reagent, Biotrace Ltd., Bridgend, UK) was added 200 μl of sterile de-ionized water to form a control reagent or 200 μl of the caged-ATP stock solution to form a caged-ATP reagent. The reagents were then incubated for 1-6 hours at 20°C.
At various times, after preparation of the reagents, sterile de-ionized water (300 μl) was transferred to a clean disposable luminometer cuvette then 100 μl of control reagent or caged-ATP reagent added. The light emitted from the reaction was quantified using a Biotrace M3 Luminometer (Biotrace Ltd, Bridgend, UK) , which integrated the light response for 10 seconds after a 2 second delay. A volume of ATP solution (10 μl, 0.1 μM) was then added to the reaction mixture and the light output measured for a second time. The cuvette, together with its contents, was then exposed to an intense flash of light from a Hanimex 325A2 flash gun (Hanimex, UK) and the light output from the reaction measured for a third time. The results in Table 1 show the light output values obtained. Several points are highlighted by -these results: (i) caged-ATP did not compete with ATP for the active site on firefly luciferase as indicated by the similar response observed to 1 pmol added ATP recorded for both, reagents (average, n = 5) of 1302 RLU from 1 pmol ATP in absence of caged-ATP and 1304 RLU from 1 pmol ATP in presence of 95.2 pmol caged-ATP) ; (ii) the high intensity light flash did not affect the rate of the firefly luciferase reaction as demonstrated by the fact that the response of the reagent to 1 pmol ATP was unchanged after flashing (1308 RLU before flashing, 1276 RLU after flashing: the difference can be solely attributed to the natural decay in luminescence associated with such reactions) ; (iii) exposure of the caged- ATP reagent to a high intensity flash of light produced an increase in ATP content in the assay, equivalent to 1.171 pmol ATP/assay. The assays could be calibrated on the basis of this response. Calibration of the assays in this way (with respect to the 1 pmol of free ATP added to the reaction) gave a value of 1.00 ± 0.08 pmol ATP/assay (mean ± S.D, n = 5) with the errors randomly distributed with respect to time. In the case of the control assays, standardized by the standard curve technique (using the data at a reagent age of l hour) , a value of 0.93 ± 0.06 pmol ATP/assay (mean ±S.D, n = 5) was obtained, with the individual values showing a marked decrease with respect to time since reagent preparation (on account of a reduction in luciferase catalytic activity) .
Once introduced into the luciferase reagent, caged-ATP might release ATP either by spontaneous hydrolysis, as a result of enzymic action, and/or by photolysis. The results shown in Example 1 indicate that release of ATP by the former two mechanisms is negligible and that, on exposure to a high intensity flash of light produced by a flashgun, ATP is produced rapidly from the caged-ATP present. Notes to Table l
1. The high intensity photoflash (provided by a Hanimex 325A2 flash gun, Hanimex, UK) did not induce luminescence from empty cuvettes, nor from cuvettes containing test solutions such as water or caged-ATP, or luciferase-luciferin reagents in the absence of caged- ATP.
2. The "ATP photostandard" (caged-ATP) produced 1.171 pmol ATP/assay on exposure to a high intensity photoflash.
This represents a 1.23% conversion rate of the caged-ATP present in the assay.
3. Similar results were obtained when the assays were performed in the presence of a detergent-based ATP extractant (swab diluent XT, Biotrace Ltd, Bridgend, UK) , instead of water, as the sample matrix indicating that the photostandardization technique is compatible with the use of such reagents.
Example 2
In a second experiment, a similar set of assays was conducted. In these experiments, the control and caged-ATP luciferin-luciferase reagents had been incubated for 6 hours prior to use. The sample mix to which the reagent was added prior to addition of ATP and/or light flashing was sterile de- ionized water, or mixtures of water and 0.1 M sodium 3,3'- dimethylglutarate buffer (pH 4.00). These experimental conditions were designed to generate a range of pH values in the final assay. The results in Table 2 show that, in the presence of increasing amounts of buffer, the light output from reactions containing 1 pmol ATP was reduced. Thus, if the standard curve approach was adopted and the results referred to those obtained using water as the sample matrix, substantial errors were evident. In the extreme', a value of 0.05 pmol ATP/assay was obtained, i.e. one-twentieth of the true value. Results based on the photostandardization technique were also subject to error but of a much smaller magnitude.
The following data provide further evidence of the utility of the photostandardization technique. A luciferase/luciferin reagent which contained caged-ATP was prepared by adding caged-ATP to Biotrace MLX reagent (Biotrace, UK) to a concentration such that each 100 μl of reagent contained 43.1 pmol of caged-ATP (ie 431 nmol/1) . This reagent was incubated overnight at 4°C to reduce the background light emission. The assays were carried out as follows. ATP was added to a series of tubes (1 pmol per tube in 10 μl sterile de-ionized water) then 290 μl of trichloroacteic acid (TCA) solution in HEPES/EDTA buffer (original pH value of the buffer was 7.75) added. Final concentrations of TCA in the solution added were 2.5 g/1, 1.25 g/1 and 0.25 g/1.
Luminescence was initiated in the case of each sample by adding 100 μl of the modified luciferase/luciferin reagent. The resulting light output was recorded in a Biotrace Multilite luminometer. The cuvette was then removed from the luminometer and exposed to a high intensity flash of light using a photoflash lamp which was mounted in a device of our own design (Serial number 005) . The cuvette was then placed back in the luminometer and the light produced by the reaction recorded for a second time.
The ATP content of each tube was calculated on the assumption that each photolysis step resulted in formation of 1.15 pmol of ATP. All tests were carried out in duplicate.
The following results were obtained. Concentration of TCA RLU sample RLU after flash ATP in sample (pmol)
0.25 g/1 15339 33406 0.976
15172 32572 1 .003
1 .25 g/l 10857 231 17 1 .01 8
10564 22990 0.978
2.5 g/l 5681 12535 0.953
5488 12291 0.928
Note : results not corrected for blank reagent light output, which was insignificant .
The results show that TCA strongly inhibited light emission when it was present at higher concentrations. Estimates of ATP content based on light emission alone would have been in serious error. However, results based on photostandardization were both reproducible and precise.
Example 3 Preparation of a series of standard solutions of known concentration using caged-ATP and varying quanta of light
Caged-ATP (Calbiochem, USA) was dissolved in sterile de- ionized water to a final concentration of 14.4 μmol/1. Portions (300 μl) of the solution were transferred to clean disposable cuvettes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis, the solutions were analysed by adding 100 μl of luciferase/luciferin reagent (Biotrace MLX reagent, Biotrace pic, UK) . The light emitted was quantified using a Biotrace Multilite luminometer which integrated the light signal for 10 seconds after a two-second delay.
The results are shown in Figure 2. ".}
(
RECTIFIED SHEET (RULE 91 ) ISA/EP The results in Figure 2 show that a 'calibration curve' could be produced in this way. This curve is analagous to that which could have been prepared by pipetting equal volumes of standard solutions of ATP, of different concentrations, into separate cuvettes. The photostandardization technique as described allowed the same result to be achieved with substantial savings in operator effort. The technique is also non-invasive in nature.
Example 4 Demonstration of cuvette phosphorescence
Different types of cuvettes, including those supplied by Lumac bv (Landgraaf, the Netherlands) and Biotrace pic (Bridgend, UK) , were exposed to a high intensity flash of polychromatic light from a photoflash lamp mounted in a sample chamber of our own design. After exposure, each cuvette was immediately transferred to the sample chamber of a Biotrace Multilite luminometer and the resulting light emission (which was associated with phosphorescence of the cuvette material) measured over a period of 100 seconds. Each experiment was repeated three times. / Figure 3 shows decay of cuvette phosphorescence with time.
The results in Figure 3 show that the intensity of the phosphorescence from the Lumac cuvettes was considerably higher than that from the Biotrace cuvettes. Furthermore, the time course of the phosphorescence was consistent for cuvettes of the same type. Experiments using an anti-static mat showed that light emission from the cuvettes was not the result of a discharge of static electricity.
By applying various filters to the light source the degree of phosphorescence could be minimized. Cuvettes obtained from Lumac bv were exposed to a high intensity flash of light which in some cases was first of all filtered, then the cuvettes were placed in a Biotrace Multilite luminometer. The light emitted was quantified at intervals. /Figure 4 shows
RECTIFIED SHEET (RULE 91) 21
the decay of cuvette phosphorescence with time for cuvettes exposed to filtered light. The responses to filtered light indicated that light in the ultra-violet region of the spectrum was responsible for cuvette phosphorescence. A range of materials was examined for phosphorescence induced by un- filtered light. The initial light emission from such materials ranged from 30 RLU to 5239 RLU (measured using a 10-second integration with a Biotrace Multilite luminometer) . These results demonstrate several points.
RECTIFIED SHEET (RULE 91) ISA/EP 22
1. Phosphorescence of cuvettes can lead to significant light emission occurring from samples exposed to the lighting conditions used to photostandardize assays.
2. Different types of cuvette vary in their ability to phosphoresce after exposure to high intensity light.
3. Filtering of the light can minimize phosphorescence (though due attention must be paid to the wavelength of light required to initiate release of analyte from
'caged' material).
4. The rate of decay of phosphorescence from such cuvettes is linear when plotted as a logarithmic plot.
Example 5 Elimination of free ATP from caged-ATP using an ATP- degrading enzyme
Caged-ATP solution (14.3 mmol/1; 10 μl) was added to 1 ml Lu it buffer (HEPES/EDTA/Mg buffer, pH 7.75; Lumac bv) containing 5 μl/ l of apyrase solution. The potato apyrase was a commercial preparation (So ase) obtained from Lumac bv and was reconstituted by adding 1 ml Lumit buffer to a vial of apyrase. At various times, 20 μl of this solution was transferred to clean disposable luminometer cuvettes containing 300 μl sterile de-ionized water. The light emitted by the sample was measured using a Biotrace Multilite luminometer (Biotrace, UK) . The cuvette was then removed from the luminometer and placed in a flash device of our own design. After receiving a single flash from a photoflash tube, the cuvette was returned to the luminometer and the light emission measured once again. Control experiments monitored the light output from reactions in which Lumit buffer was added to the sample of caged-ATP, rather than apyrase solution.
The following results were obtained. 23 without apyrase with apyrase before flash after flash before flash after'flash
5 minutes 389211 >1000000 34844 837480
15 minutes 400630 944471 1497 790266
30 minutes 441410 >1000000 830 859374
60 minutes 413305 995498 754 782365
Note: the luminometer can not measure light outputs in excess of 1000000 RLU. Counts approaching this limit may behave in a non-linear way.
These results show that apyrase can be used to eliminate contaminant ATP from supplies of caged-ATP. Also, apyrase does not attack caged ATP. The variation in the results can be attributed to measurement errors at the high levels of ATP used.
Example 6 Standardization of tests using freeze-dried 'caged' material in disposable sample cuvettes
A solution of caged-ATP (14.3 mmol/1; 10 μl) was transferred to 1 ml HEPES/EDTA/Mg buffer, pH 7.75 (Lumit buffer, Lumac bv) and 5 μl of a solution of potato apyrase added. The potato apyrase was a commercial preparation (Somase) obtained from Lumac bv and was reconstituted by adding 1 ml Lumit buffer to a vial of apyrase. The solution of caged-ATP containing the apyrase was incubated at 20°C for 40 min then diluted 1:1 with Lumit buffer. Portions (1 μl) of the solution were transferred to clean disposable plastic cuvettes (obtained from Biotrace pic) . This procedure resulted in each cuvette containing 143 pmol of caged-ATP. The cuvettes were then placed in a vacuum desiccator and freeze-dried at - 55°C under vacuum for two hours.
After freeze-drying, the cuvettes were tested as follows. Sterile, de-ionized water (300 μl) was transferred to each cuvette then 100 μl luciferase/luciferin reagent (Biotrace MLX 24 reagent, Biotrace pic) added. The light emitted was recorded using a Biotrace Multilite luminometer, then ATP Was released from the caged-ATP present using a photoflash lamp contained in a device constructed at BRF International (Box serial number 002) . The following results were obtained on replicate cuvettes,
blank value (RLU) value after flashing(RLU)
Cuvette 1 2883 90931
Cuvette 2 2882 92759
Cuvette 3 2598 90078
Cuvette 4 2944 84657
ATP could also be released from the freeze-dried material contained in the cuvettes by flashing, prior to addition of any samples or reagents to the cuvette. In performing such tests, the following results were obtained.
blank value obtained after flashing dry cuvette (RLU) * value after flashing (RLU)
Cuvette 1 49170 133736
Cuvette 2 75870 141760
Cuvette 3 34206 116517
* Reagents added as in previous tests.
These results show that ATP can be released from caged- ATP even in the presence of very low quantities of water. Thus, if desired, assay protocols could be devised in which ATP, or other analytes, are released from the 'caged' molecule before any liquid steps of the assay. In some cases, this may be a convenient way of standardizing certain tests. 25
Example 7 Preparation of a series of standard solutions of known concentration using caged-arachidonic acid' and varying quanta of light
Caged-arachidonic acid (Molecular Probes Inc, USA; product number A-7062) is dissolved in HEPES/EDTA buffer (pH 7.75) to a final concentration of 14.4 μmol/1. Portions (100 μl) of the solution are transferred to clean disposable tubes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis, the solutions are analysed using any method suitable for quantification of arachidonic acid, such as HPLC, GC/MS, TLC or specific enzymic methods.
A 'calibration curve' can be produced in this way which is analagous to that which could have been prepared by pipetting equal volumes of standard solutions, of different concentrations, into separate vials. The photostandardization technique as described allowed the same result to be achieved with substantial savings in operator effort. The technique is also non-invasive in nature.
Example 8 Preparation of a series of standard solutions of known concentration using caged-penicillin V and varying quanta of light
Caged-penicillin V (Molecular Probes Inc, USA: product number P-7061) is dissolved in HEPES/EDTA buffer (pH 7.75) to a final concentration of 14.4 μmol/1. Portions (100 μl) of the solution are transferred to clean disposable tubes then subjected to between one and 10 flashes using a Hanimex flashgun. After photolysis the solutions are analysed using any method suitable for quantification of penicillin V, for example using an ELISA test.
A, 'calibration curve' can be produced in this way which is analagous to that which could have been prepared by pipetting equal volumes of standard solutions, of different 26 concentrations, into separate vials. The photostandardization technique as described allowed the same result to be achieved with substantial savings in operator effort. •■ The technique is also non-invasive in nature.
Examples of other caged analytes which could be used in methods analagous to examples 7 and 8 include caged aspartic acid (Molecular Probes Inc USA: product number A-2505) , caged L-lysine (Molecular Probes Inc USA: product number B-7099) , caged L-epinephrine (Molecular Probes Inc USA: product number D-7057) , caged L-dopamine (Molecular Probes Inc USA: product number D-7064) , caged L-phenylalanine (Molecular Probes Inc USA: product number D-7093) and caged D-luciferin (Molecular Probes Inc USA: product number L-7085) .
Table 1 : Use of caged-ATP to standardize ATP assays over the course of a working day
UGHT OUTPUT (RLU*) CALCULATED ATP CON¬ TENT (pmol/assay) OF
Time since No added ATP + 1 pmol ATP + Light flash STANDARD BASED ON preparation control caged-ATP control caged-ATP control caged-ATP (ϊ) standard (ii) photo¬ of reagent (h) reagent reagent reagent reagent reagent reagent curve at Ts lti standardization
1 7 69 1 0S 1495 1419 3129 1.00 1.02
2 7 20 1372 1377 1320 2875 0.98 1.06 to
4 6 57 1315 1367 1308 3014 0.94 0.93
5 6 80 1262 1258 1211 2786 0.90 0.90
6 5 24 1185 1271 1121 2616 0.84 1.09
X 0.93 1.00
* RLU = relative light unit
Table 2: Use of caged-ATP to standardize ATP assays at different pH values
UGHT OUTPUT (RLU*) CALCULATED ATP CONTENT (pmol/assay) OF
No added ATP + 1 pmol ATP + Light flash STANDARD BASED
Test Sample Mix ON control caged-ATP control caged-ATP control caged-ATP (i) standard (7i) photo¬ reagent reagent reagent reagent reagent reagent curve at standardization T= 1h l\)
Sterile de-Ionized water 6 24 1185 1271 1121 2616 1.00 1.09 00
Water/NaDMG' buffer (250: 50) 9 21 949 871 912 2427 0.80 0.64
Water/NaDMG* buffer (150:150) 10 13 378 430 392 1056 0.31 0.78
Water/IMaDMG* buffer ( 0:300) 8 8 72 65 84 217 0.05 0.44
* RLU a relative light unit
f NaDMG = 0.1 M sodium 3,3'-dimethylglutarate buffer, pH 4.00

Claims

29CLAIMS
1. A method for internally standardizing a chemical assay comprising the steps:
i) adding a pre-determined, amount of photosensitive derivative of an analyte a sample to be assayed; ii) measuring a test property of the assay; iii) exposing the sample/photosensitive derivative mix to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of analyte; iv) re-measuring the test property; v) repeating steps iii) and iv) inclusive from zero-n times as desired; vi) calculating the change in the test property measurements; and vii) using the calculated value(s) from step (vi) as a standard to determine the amount of analyte originally present in the sample.
2. A method according to claim 1 wherein the photosensitive derivative of the analyte is a caged form of the analyte.
3. A method according to claim 2 wherein the derivative of the analyte is pre-treated to reduce contamination by uncaged forms of the derivative of the analyte.
4. A method according to claims 1, 2 or 3 wherein the caged derivative of the analyte is freeze-dried onto a carrier.
5. A method according to any one of the preceding claims including an additional step to compensate for any inherent phosphorescence of assay materials or equipment. 30
6. A method for externally standardizing a chemical assay comprising the steps:
i) exposing a pre-determined amount of photosensitive derivative of an analyte to a flash of visible light of pre-determined duration ajnd intensity to release from the photosensitive derivative a known amount of analyte; ii) measuring a test property of the assay; iii) repeating steps i) and ii) inclusive from zero-n times as desired; iv) calculating the change in the test property measurements; and v) using the calculated values from step (iv) as a standard against which results of an assayed sample can be compared.
7. A method according to claim 6 wherein the photosensitive derivative of the analyte is a caged form of the analyte.
8. A method according to claim 7 wherein the derivative of the analyte is pre-treated to reduce contamination by uncaged forms of the derivative of the analyte.
9. A method according to claims 6, 7 or 8 wherein the caged derivative of the analyte is freeze dried onto a carrier.
10. A method according to any one of claims 6 - 9 including an additional step to compensate for any inherent phosphorescence of assay materials or equipment.
11. A method for standardizing an ATP-bioluminescence assay comprising the steps: 31 i) incorporating a pre-determined amount of a photosensitive derivative of ATP into a firefly luciferase - luciferin reagent,
ii) measuring the light emitted by the reagent; iii) mixing a sample to be assayed with the reagent; iv) re-measuring the light emitted by the luminescent reaction; v) exposing the sample/reagent mixture to a flash of visible light of pre-determined duration and intensity to release from the photosensitive derivative a known amount of ATP; vi) re-measuring the light emitted by the luminescent reaction; vii) repeating steps v) and vi) inclusive from zero-n times as desired; viii) calculating the change in light emission measurements; and ix) using the calculated value(s) from step (vii) as a standard to determine the amount of ATP originally present in the sample.
12. A method according to claim 11 wherein the photosensitive derivative of ATP is a caged form of ATP.
13. A method according to claim 12 wherein the caged form of ATP is a nitrophenol ester of ATP.
14. A method according to claims 11, 12 and 13 wherein the luciferase-luciferin reagent containing the caged ATP is pre- treated by incubation for 8 - 20 hours or more at 4°C so as to eliminate contaminant ATP molecules.
15. A method according to claims 11, 12 and 13 wherein the caged ATP is pre-treated with an ATP degrading enzyme so as to eliminate contaminant ATP molecules. 32
16. A method according to any one of claims 11 - 15 including an additional step to compensate for any inherent phosphorescence of assay materials or equipment.
17. A method according to any one of claims 11 - 15 wherein the caged ATP is freeze-dried onto a carrier.
18. A kit for standardising an ATP bioluminescence assay comprising: 1) an assay buffer
2) a photosensitive derivative of ATP; and
3) a firefly luciferase-luciferin reagent
19. A kit according to claim 13 further comprising: 4) a luminometer; and
5) a high intensity light source
EP95914453A 1994-04-06 1995-04-06 Methods for calibrating chemical assays Expired - Lifetime EP0756637B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406737A GB2288232A (en) 1994-04-06 1994-04-06 Photosensitive derivatives of ATP as assay control standards
GB9406737 1994-04-06
PCT/GB1995/000794 WO1995027797A1 (en) 1994-04-06 1995-04-06 Methods for calibrating chemical assays

Publications (2)

Publication Number Publication Date
EP0756637A1 true EP0756637A1 (en) 1997-02-05
EP0756637B1 EP0756637B1 (en) 1998-12-02

Family

ID=10753046

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95914453A Expired - Lifetime EP0756637B1 (en) 1994-04-06 1995-04-06 Methods for calibrating chemical assays

Country Status (12)

Country Link
US (1) US5801007A (en)
EP (1) EP0756637B1 (en)
JP (1) JPH09511581A (en)
CN (1) CN1070920C (en)
AT (1) ATE174062T1 (en)
DE (1) DE69506394T2 (en)
DK (1) DK0756637T3 (en)
ES (1) ES2124542T3 (en)
FI (1) FI964003A (en)
GB (3) GB2288232A (en)
RU (1) RU2135586C1 (en)
WO (1) WO1995027797A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210891B1 (en) * 1996-09-27 2001-04-03 Pyrosequencing Ab Method of sequencing DNA
US6258568B1 (en) 1996-12-23 2001-07-10 Pyrosequencing Ab Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876995A (en) 1996-02-06 1999-03-02 Bryan; Bruce Bioluminescent novelty items
US6117394A (en) * 1996-04-10 2000-09-12 Smith; James C. Membrane filtered pipette tip
ATE290205T1 (en) 1996-12-12 2005-03-15 Prolume Ltd DEVICE AND METHOD FOR DETECTING AND IDENTIFYING INFECTIOUS ACTIVE SUBSTANCES
JP2002507410A (en) 1998-03-27 2002-03-12 プロルーム・リミテッド Luciferases, fluorescent proteins, nucleic acids encoding luciferases and fluorescent proteins and their use in diagnostics, high-throughput screening and novel items
DE19838429C2 (en) * 1998-08-24 2001-07-26 Fraunhofer Ges Forschung Arrangement for the rapid detection of microbiological or biochemical substances
US6216049B1 (en) * 1998-11-20 2001-04-10 Becton, Dickinson And Company Computerized method and apparatus for analyzing nucleic acid assay readings
US6653147B2 (en) 2000-03-31 2003-11-25 Neogen Corporation Apparatus and method for chemiluminescent assays
US6927851B2 (en) 2000-03-31 2005-08-09 Neogen Corporation Methods and apparatus to improve the sensitivity and reproducibility of bioluminescent analytical methods
CA2328684A1 (en) * 2000-12-15 2002-06-15 Yahia Gawad Photon-triggered luminescent assay
US6601006B2 (en) * 2000-12-22 2003-07-29 Idexx Laboratories, Inc. Methods for the calibration of analyte assays
WO2004045547A2 (en) * 2002-11-18 2004-06-03 Genospectra, Inc. Rnai-based sensors, caged interfering rnas, and methods of use thereof
US7271886B2 (en) * 2002-11-18 2007-09-18 Panomics, Inc. Uncaging device
GB0301384D0 (en) * 2003-01-22 2003-02-19 Lux Biotechnology Device
US7795034B2 (en) * 2003-07-03 2010-09-14 Wako Pure Chemical Industries, Ltd. Specific component measuring method by spectral measurement
CN1304598C (en) * 2004-08-13 2007-03-14 湖南大学 ATP and NAD and method for analysis of associated enzyme and substrate
JP2015154353A (en) * 2014-02-17 2015-08-24 三菱電機株式会社 High frequency power amplifier and method of manufacturing the same
CN112098384B (en) * 2020-09-22 2023-09-01 华东交通大学 Simple method for rapidly predicting whether water quality is biostable

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616253A (en) * 1967-05-01 1971-10-26 Du Pont Method for determining bacterial populations
GB1604249A (en) * 1977-05-31 1981-12-02 Kolehmainen S Selective measurement of somatic and microbial cells
GB8529684D0 (en) * 1985-12-02 1986-01-08 Medical Res Council Photo-labile protecting agents
SE8703675L (en) * 1987-09-23 1989-03-24 Life Science International Ab LUMINOMETRIC ANALYSIS ON CELLULATED ATP
EP0563858B1 (en) * 1992-04-01 1997-07-09 Nihon Millipore Kogyo Kabushiki Kaisha Method of determining viable count
US5366873A (en) * 1992-06-03 1994-11-22 Gideon Eden Device and method for use in detecting microorganisms in a sample

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9527797A1 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210891B1 (en) * 1996-09-27 2001-04-03 Pyrosequencing Ab Method of sequencing DNA
US6258568B1 (en) 1996-12-23 2001-07-10 Pyrosequencing Ab Method of sequencing DNA based on the detection of the release of pyrophosphate and enzymatic nucleotide degradation

Also Published As

Publication number Publication date
US5801007A (en) 1998-09-01
DK0756637T3 (en) 1999-08-16
FI964003A0 (en) 1996-10-04
CN1148870A (en) 1997-04-30
RU2135586C1 (en) 1999-08-27
GB2288232A (en) 1995-10-11
ATE174062T1 (en) 1998-12-15
GB2301436A (en) 1996-12-04
ES2124542T3 (en) 1999-02-01
JPH09511581A (en) 1997-11-18
EP0756637B1 (en) 1998-12-02
WO1995027797A1 (en) 1995-10-19
DE69506394D1 (en) 1999-01-14
GB9620993D0 (en) 1996-11-27
DE69506394T2 (en) 1999-08-26
GB2301436B (en) 1998-02-18
GB9406737D0 (en) 1994-05-25
FI964003A (en) 1996-10-04
CN1070920C (en) 2001-09-12

Similar Documents

Publication Publication Date Title
US5801007A (en) Methods for calibrating chemical assays
EP0695363B1 (en) Detection of biological material
Lust et al. The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts
KR920010312B1 (en) Measurement of Potassium Ion in Fluid
US3668076A (en) Diagnostic agent
CA2194458A1 (en) Method for detecting microorganism
US20060199238A1 (en) ADP detection using an enzyme-coupled reaction
Kawasaki et al. Determination of inorganic phosphate by flow injection method with immobilized enzymes and chemiluminescence detection
CA2194457C (en) Microbiological test method and reagents
US3925162A (en) Method for simultaneous determination of enzymatic activities of enzymes
AU720542B2 (en) Improved chemiluminescent 1,2-dioxetanes
WO1997014954A9 (en) Improved chemiluminescent 1,2-dioxetanes
CA2445941A1 (en) Visually determinable atp measuring method and reagent therefor
JPH06217799A (en) Method of measuring substance
JPH04507194A (en) Chemiluminescent compositions, chemiluminescent methods, and their use in analytical assays
Kamoun et al. Ultramicromethod for determination of plasma uric acid.
JPS60210998A (en) Test composition, test kit and method for enzymatical measurement of inorganic phosphate
JPH0576397A (en) Determination of substance
CA2000963A1 (en) Method of assaying magnesium
SU1752766A1 (en) Method for determination of ammonium ions quantity in solution
JPH09262098A (en) Measurement of ingredient in food and device therefor
Kirkland et al. Serum glutamic-oxalacetic transaminase
SU1449588A1 (en) Method of determining the activity of alkaline phosphotase
EP0022757A1 (en) Method for determining creatine kinase in samples containing ATP
WO2004076691A1 (en) Amp assay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19961031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

17Q First examination report despatched

Effective date: 19970509

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

REF Corresponds to:

Ref document number: 174062

Country of ref document: AT

Date of ref document: 19981215

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69506394

Country of ref document: DE

Date of ref document: 19990114

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2124542

Country of ref document: ES

Kind code of ref document: T3

ITF It: translation for a ep patent filed

Owner name: STUDIO TORTA S.R.L.

ET Fr: translation filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: HUG INTERLIZENZ AG

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20020313

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20020409

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20020411

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20020412

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20020415

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20020416

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20020418

Year of fee payment: 8

Ref country code: IE

Payment date: 20020418

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20020423

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20020508

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20020510

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030406

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030406

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030407

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030407

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030430

BERE Be: lapsed

Owner name: *BRF INTERNATIONAL

Effective date: 20030430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031101

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031101

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20030406

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20031101

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20031231

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20030407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050406